Influence of Bacille Calmette-Guérin on tuberculin skin testing in Venezuelan Amerindians in high tuberculosis burden areas

Journal of Infection in Developing Countries

Volumn 8, Issue 2, 2014, Pages 176-183

  Maes, Mailis ^a   Verhagen, Lilly M ^a,b   Ortega, Dagmarys ^c   Sánchez, Gregorio L ^c   Segovia, Yajaira ^d   del Nogal, Berenice ^e,f   de Waard, Jacobus H ^a,e  

^a INSTITUTO DE BIOMEDICINA   (Venezuela)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Servicio Autonomo Centro Amazonico de Investigacion y Control de Enfermedades Tropicales   (Venezuela)

^d Ministerio de Salud Estado Delta Amacuro   (Venezuela)

^e UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^f Hospital de Ninos J M de los Rios   (Venezuela)

Author keywords

Amerindians; BCG vaccination; Tuberculin skin test

Indexed keywords

ADOLESCENT; BCG VACCINE; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INFANT; LINEAR MODELS; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; MYCOBACTERIUM BOVIS; PREVALENCE; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME; TUBERCULIN TEST; TUBERCULOSIS; VACCINATION; VENEZUELA;

EID: 84893953728     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.3297     Document Type: Article

References (29)

1. Lalvani A, Millington KA (2007) T cell-based diagnosis of childhood tuberculosis infection. Curr Opin Infect Dis 20: 264-271.
2. Lalvani A, Pareek M (2010) Interferon gamma release assays: principles and practice. Enferm Infecc Microbiol Clin 28: 245-252.
3. Pai M, Kalantri S, Dheda K (2006) New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. Expert Rev Mol Diagn 6: 413-422.
4. World Health Organization (2006) Guidance for national tuberculosis programmes on the management of tuberculosis in children. Geneva, Switzerland available: http://www.who.int/maternal_child_adolescent/documents/ht m_tb_2006_371/en/index.html last accessed 27 March 2013.
5. World Health Organization. Immunization surveillance, assesment and monitoring. Immunization profile - Venezuela (Bolivarian Republic of). Available http://www.WHO.int/immunization_monitoring/data/ven.pdf. Accessed 15 January 2011.
6. Pan American Health Organization (PAHO). Plan regional detuberculosis 2006-2015.Available: http://www.paho.org/spanish/ad/dpc/cd/tb-reg-plan-2006-15.pdf. Accessed 5 January 2013.
7. Fernández de Larrea C, Fandiño C, López D, del Nogal B, Rodríguez N, Convit J, Araujo Z, de Waard JH (2002) Tuberculosis in subjects under 15 years of age in the population of Warao in Venezuela. Invest Clin. 43: 35-48.
8. Castillo A, Chaumer S, Holguin W, Manzini B, Morris M, Paris R, Sanchez G, Tuberculosis en el indígena. Reunion de expertos en astma y tuberculosis 20-22 de junio 1997. Isla de Margarita, Venezuela. Folleto 1997; Page 55.
9. Guilarte AJ, España MF, Mendez RJ, Vasquez de Salas A. Programa National de Tuberculosis. Normas oficial Venezolana del programa nacional integrado de control de la tuberculosis. Manual para coordinadores y laboratorio 2006.
10. Luman ET, Ryman TK, Sablan M (2009) Estimating vaccination coverage: validity of household-retained vaccination cards and parental recall. Vaccine 27: 2534-2539.
11. Rieder HL, Chadha VK, Nagelkerke NJ, van Leth F, van der Werf MJ, KNCV Tuberculosis Foundation (2011) Guidelines for conducting tuberculin skin test surveys in high-prevalence countries. Int J Tuberc Lung Dis 15: S1-25.
12. CDC (2000) Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR 49 (No. RR-6): 1-51.
13. Farhat M, Greenaway C, Pai M (2006) False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 10: 1192-1204.
14. Sousa AO, Salem JI, Lee FK, Verçosa MC, Cruaud P, Bloom BR, Lagrange PH, David HL (1997) An epidemic of tuberculosis with a high rate of tuberculin anergy among a population previously unexposed to tuberculosis, the Yanomami Indians of the Brazilian Amazon. Proc Natl Acad Sci USA 94: 13227-13232.
15. Araujo Z, de Waard JH, de Larrea CF, Borges R, Convit J (2008) The effect of Bacille Calmette-Guérin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis. Vaccine 26: 5575-5581.
16. Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM (2002) A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements. Thorax 57: 804-809.
17. World Health Organization. Global Tuberculosis Report 2012. Geneva, Switzerland
18. Dilektasli AG, Erdem E, Durukan E, Eyüboǧlu FÖ(2010) Is the T-cell-based interferon-gamma releasing assay feasible for diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country? Jpn J Infect Dis 63: 433-436.
19. Higuchi K, Kondo S, Wada M, Hayashi S, Ootsuka G, Sakamoto N, Harada NJ (2009) Contact investigation in a primary school using a whole blood interferon-gamma assay. Infect 58: 352-357.
20. Lienhardt C, Fielding K, Sillah J, Tunkara A, Donkor S, Manneh K, Warndorff D, McAdam KP, Bennett S (2003) Risk factors for tuberculosis infection in Sub-Saharan Africa. Am J Respir Crit Care Med 168: 448-455.
21. Almeida LM, Barbieri MA, Da Paixão AC, Cuevas LE (2001) Use of purified protein derivative to assess the risk of infection in children in close contact with adults with tuberculosis in a population with high Calmette-Guérin bacillus coverage. Pediatr Infect Dis J 20: 1061-1065.
22. Rose MV, Kimaro G, Nissen TN, Kroidl I, Hoelscher M, Bygbjerg IC, Mfinanga SG, Ravn P (2012) QuantiFERON®-TB gold in-tube performance for diagnosing active tuberculosis in children and adults in a high burden setting. PLoS One 7: e37851.
23. Dheda K, van Zyl Smit R, Badri M, Pai M (2009) T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings. Curr Opin Pulm Med. 15: 188-200.
24. Romero-Amaro Z, Bracho A, Atencio R, Romero-Gori N, Montiel C (2008) Prevalencia de tuberculosis pulmonar en pacientes indígenas y no indígenas del estado Zulia durante el periodo 1996-2005. Kasmera. 36: 159-168.
25. Piñate FM, Rovira JMA (2007) Estado actual de la lucha antituberculosa en Venezuela. Gaceta Médica de Caracas 115: 325-334.
26. Möller M, Hoal EG (2010) Current findings, challenges and novel approaches in human genetic susceptibility to tuberculosis Tuberculosis (Edinb) 90: 71-83.
27. Verhagen LM, Hermans PWM, Warris A, De Groot R, Maes M, Villalba JA, Del Nogal B, Van Den Hof, S, Mughini Gras L, Van Soolingen D, Pinellis E, De Waard JH (2012) Helminths and skewed cytokine profiles increase tuberculin skin test positivity in Warao Amerindians. Tuberculosis 92: 505-512.
28. Mahomed H, Hawkridge T, Verver S, Geiter L, Hatherill M, Abrahams DA, Ehrlich R, Hanekom WA, Hussey GD, SATVI Adolescent Study Team (2011) Predictive factors for latent tuberculosis infection among adolescents in a high- burden area in South Africa. Int J Tuberc Lung Dis 15: 331-336.
29. Montenegro RA, Stephens C (2006) Indigenous health in Latin America and the Caribbean. Lancet 367: 1859-1869.